Docosahexaenoic acid neurolipidomics

Prostaglandins and Other Lipid Mediators

Volumn 91, Issue 3-4, 2010, Pages 85-89

  Niemoller, Tiffany D ^a   Bazan, Nicolas G ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Docosahexaenoic acid; Ischemia reperfusion; Mediator lipidomics; Neuroprotectin D1; Omega 3 fatty acids

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CELL NUCLEUS RECEPTOR; CILIARY NEUROTROPHIC FACTOR; CYTOCHROME C; DOCOSAHEXAENOIC ACID; FATTY ACID; FIBROBLAST GROWTH FACTOR 2; FORKHEAD TRANSCRIPTION FACTOR; GAMMA INTERFERON; GELATINASE B; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLYCOGEN SYNTHASE KINASE 3BETA; INTERLEUKIN 1BETA; LEUKEMIA INHIBITORY FACTOR; MAMMALIAN TARGET OF RAPAMYCIN; NERVE GROWTH FACTOR; NEUROPROTECTIN D1; NEUROTROPHIN; NEUROTROPHIN 3; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PHOSPHATIDYLSERINE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PIGMENT EPITHELIUM DERIVED FACTOR; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AGING; ANTIINFLAMMATORY ACTIVITY; BINDING AFFINITY; BIOGENESIS; BIOMICS; BRAIN FUNCTION; BRAIN ISCHEMIA; CAUSE OF DEATH; CELL DAMAGE; COGNITIVE DEFECT; DIET; DISABILITY; DRUG ACTIVITY; ENZYME ACTIVITY; HUMAN; LIPID METABOLISM; LIPOGENESIS; MEMORY; NEUROLIPIDOMICS; NEUROPROTECTION; OXIDATIVE STRESS; PHOTORECEPTOR; PRECURSOR; PROTEIN TRANSPORT; REGULATORY MECHANISM; REPERFUSION INJURY; REVIEW; RISK REDUCTION; SIGNAL TRANSDUCTION; STROKE; SYNAPTIC POTENTIAL;

ANIMALS; DOCOSAHEXAENOIC ACIDS; HUMANS; LIPID METABOLISM; NERVOUS SYSTEM; PROTO-ONCOGENE PROTEINS C-AKT; STROKE;

EID: 77949489156     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2009.09.005     Document Type: Review

References (40)

1. Bazan N.G., Marcheselli V.L., Lu Y., Hong S., and Jackson F. Lipidomic approaches to neuroprotection signaling in the retinal pigment epithelium. In: Fliesler S.J., and Kisselev O.G. (Eds). Signal transduction in the retina (2008) 349-373 [chapter 15]
2. Bazan N.G. Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors. Trends Neurosci 29 (2006) 263-271
3. Scott B.L., and Bazan N.G. Membrane docosahexaenoate is supplied to the developing brain and retina by the liver. Proc Natl Acad Sci USA 86 (1989) 2903-2907
4. Bazan N.G. Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor. J Lipid Res 44 (2003) 2221-2233
5. Uauy R., and Dangour A.D. Nutrition in brain development and aging: role of essential fatty acids. Nutr Rev 64 (2006) S24-S33
6. Fotuhi M., Mohassel P., and Yaffe K. Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease. Nat Clin Pract Neurol 5 (2009) 140-152
7. Bazan N.G. Homeostatic regulation of photoreceptor cell integrity: significance of the potent mediator neuroprotectin D1 biosynthesized from docosahexaenoic acid: the Proctor Lecture. Invest Ophthalmol Vis Sci 48 (2007) 4866-4881
8. Neuringer M., Connor W.E., Lin D.S., Barstad L., and Luck S. Biochemical and functional effects of prenatal and postnatal omega 3 fatty acid deficiency on retina and brain in rhesus monkeys. Proc Natl Acad Sci USA 83 (1986) 4021-4025
9. Calandria J.M., Marcheselli V.L., Mukherjee P.K., et al. Selective survival rescue in 15-lipoxygenase-1-deficient retinal pigment epithelial cells by the novel docosahexaenoic acid-derived mediator, neuroprotectin D1. J Biol Chem 284 (2009) 17877-17882
10. Marcheselli VL, Mukherjee PK, Arita M, et al. Neuroprotectin D1/Protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and leukocytes. Prostaglandins Leukot Essent Fatty Acids; in press.
11. Mukherjee P.K., Marcheselli V.L., Serhan C.N., and Bazan N.G. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci USA 101 (2004) 8491-8496
12. Mukherjee P.K., Marcheselli V.L., Barreiro S., Hu J., Bok D., and Bazan N.G. Neurotrophins enhance retinal pigment epithelial cell survival through neuroprotectin D1 signaling. Proc Natl Acad Sci USA 104 (2007) 13152-13157
13. Lukiw W.J., Cui J.G., Marcheselli V.L., et al. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest 115 (2005) 2774-2783
14. Marcheselli V.L., Hong S., Lukiw W.J., et al. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem 278 (2003) 43807-43817
15. http://stroke.nih.gov/materials.
16. Caplan L.R. Improving stroke prevention and treatment now. Cerebrum (2006) 2-11
17. Adams Jr. H.P., Brott T.G., Furlan A.J., et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. Circulation 94 (1996) 1167-1174
18. O'Collins V.E., Macleod M.R., Donnan G.A., et al. 1,026 experimental treatments in acute stroke. Ann Neurol 59 (2006) 467-477
19. Kaufmann W.E., Worley P.F., Pegg J., Bremer M., and Isakson P. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc Natl Acad Sci USA 93 (1996) 2317-2321
20. Marcheselli V.L., and Bazan N.G. Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus. Inhibition by a platelet-activating factor antagonist. J Biol Chem 271 (1996) 24794-24799
21. McCullough L., Wu L., Haughey N., et al. Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia. J Neurosci 24 (2004) 257-268
22. Liu D., Wu L., Breyer R., Mattson M.P., and Andreasson K. Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia. Ann Neurol 57 (2005) 758-761
23. Kawano T., Anrather J., Zhou P., et al. Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat Med 12 (2006) 225-229
24. Serhan C.N., Hong S., Gronert K., et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 196 (2002) 1025-1037
25. Hong S., Gronert K., Devchand P.R., Moussignac R.L., and Serhan C.N. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J Biol Chem 278 (2003) 14677-14687
26. Duffield J.S., Hong S., Vaidya V.S., et al. Resolvin D series and protectin D1 mitigate acute kidney injury. J Immunol 177 (2006) 5902-5911
27. Belayev L., Marcheselli V.L., Khoutorova L., et al. Docosahexaenoic acid complexed to albumin elicits high-grade ischemic neuroprotection. Stroke 36 (2005) 118-123
28. Alessi D.R., Andjelkovic M., Caudwell B., et al. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 15 (1996) 6541-6551
29. Sarbassov D.D., Guertin D.A., Ali S.M., and Sabatini D.M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307 (2005) 1098-1101
30. Zhao H., Sapolsky R.M., and Steinberg G.K. Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke. Mol Neurobiol 34 (2006) 249-270
31. Kim H.Y. Novel metabolism of docosahexaenoic acid in neural cells. J Biol Chem 282 (2007) 18661-18665
32. Akbar M., Calderon F., Wen Z., and Kim H.Y. Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. Proc Natl Acad Sci USA 102 (2005) 10858-10863
33. Guo M., Stockert L., Akbar M., and Kim H.Y. Neuronal specific increase of phosphatidylserine by docosahexaenoic acid. J Mol Neurosci 33 (2007) 67-73
34. Lengqvist J., Mata De Urquiza A., Bergman A.C., et al. Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor alpha ligand-binding domain. Mol Cell Proteomics 3 (2004) 692-703
35. Itoh T., Fairall L., Amin K., et al. Structural basis for the activation of PPARgamma by oxidized fatty acids. Nat Struct Mol Biol 15 (2008) 924-931
36. Banga A., Unal R., Tripathi P., et al. Adiponectin translation is increased by the PPARgamma agonists pioglitazone and omega-3 fatty acids. Am J Physiol Endocrinol Metab 296 (2009) E480-E489
37. Tontonoz P., and Spiegelman B.M. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem 77 (2008) 289-312
38. Sundararajan S., Gamboa J.L., Victor N.A., Wanderi E.W., Lust W.D., and Landreth G.E. Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia. Neuroscience 130 (2005) 685-696
39. Wu J.S., Cheung W.M., Tsai Y.S., et al. Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 epsilon upregulation. Circulation 119 (2009) 1124-1134
40. Zapata-Gonzalez F., Rueda F., Petriz J., et al. Human dendritic cell activities are modulated by the omega-3 fatty acid, docosahexaenoic acid, mainly through PPAR(gamma):RXR heterodimers: comparison with other polyunsaturated fatty acids. J Leukoc Biol 84 (2008) 1172-1182